Requires insurance coverage for one rescue and one maintenance inhaler at no cost.
Summary
S01804 would amend New York’s insurance law to require most health insurance policies that cover prescription drugs to also cover asthma inhalers. The mandate applies to individual, group, blanket, medical expense indemnity, and health service corporation policies that provide comprehensive medical coverage. For each covered policy, insurers would have to provide at least one rescue inhaler and one maintenance inhaler for asthma when prescribed by an authorized health care provider.
The bill specifies that the required inhalers must be covered with no deductible, copayment, coinsurance, or other cost-sharing requirement. It also includes an exception for high-deductible health plans: if eliminating cost-sharing would make a plan incompatible with health savings account eligibility, the coverage may remain subject to the annual deductible. The bill would take effect January 1, 2027, and would apply to policies and contracts issued, renewed, modified, altered, or amended on or after that date.
Impact
If enacted, the bill would add a new mandated benefit to New York insurance law and require insurers and health plans to cover asthma inhalers at no cost in most comprehensive prescription-drug plans. It would directly affect insurers, health maintenance-type coverage, and related policy forms by establishing a statewide minimum coverage standard for asthma rescue and maintenance inhalers. The measure would also create a limited carveout for certain high-deductible health plans to preserve federal health savings account eligibility.
Sentiment
The available context suggests generally favorable treatment of the bill, with no recorded votes or committee transcript opposition in the provided materials. The bill was introduced, amended, and recommitted, which indicates it advanced through the committee process without any documented controversy in the record provided. Its caption and structure reflect a consumer-protection and affordability approach aimed at reducing out-of-pocket costs for asthma treatment.
Contention
The main policy issue embedded in the bill is the balance between eliminating patient cost-sharing and preserving the tax-advantaged status of high-deductible health plans tied to health savings accounts. That exception suggests concern from insurers or plan administrators about federal compatibility, while the core mandate is likely supported by advocates for lower prescription-drug costs and asthma patients. No specific opposing arguments, amendments, or recorded vote splits are provided in the supplied materials.
Expands coverage for the treatment of asthma to include a second rescue and maintenance inhaler, along with any medically necessary devices for children under nineteen years of age.
Expands coverage for the treatment of asthma to include a second rescue and maintenance inhaler, along with any medically necessary devices for children under nineteen years of age.